MindWalk Holdings Corp.

Revenue for Q1 fiscal 2027 was CAD 3.8 million, up from CAD 3.2 million in Q1 fiscal 2026, an increase of about CAD 673,000 or 21%. Gross margin was CAD 2.2 million, or 59%, versus CAD 1.5 million, or 48%, last year. Net loss and loss from continuing operations was CAD 6.1 million, compared with CAD 4.1 million in the prior-year quarter; the prior-year overall net loss was CAD 3 million, including CAD 1.1 million of income from discontinued operations. Cash ended the quarter at CAD 7.6 million, versus CAD 11.3 million at April 30, and net cash used in operating activities was CAD 4 million. Management did not give formal next-quarter or full-year financial guidance, but said revenue growth may be lumpy as ReefIQ agreements are milestone-based at first and then convert to annual recurring revenue.

Jennifer Bath framed the quarter as a transition toward a larger AI drug discovery platform business, centered on ReefIQ and broader platform partnerships. She emphasized that ReefIQ is now launched, that multiple large pharma companies are in active discussions, and that these opportunities are larger than historical LensAI contracts. Her tone was confident and assertive, stressing that MindWalk’s long-standing pharma relationships, wet-lab track record, and integrated data context give it a distribution advantage that new entrants cannot easily replicate.

Scott Areglado focused on the quarter’s growth metrics and the cost of building commercial infrastructure. He cited revenue of CAD 3.8 million, gross margin of 59%, R&D of CAD 1.3 million, sales and marketing of CAD 3.2 million, G&A of CAD 3.9 million, and net loss from continuing operations of CAD 6.1 million. He said the company ended with CAD 7.6 million of cash, used CAD 4 million in operating cash, and now has a binding commitment for a CAD 30 million senior unsecured revolving credit facility that will be drawn as needed after the credit agreement is completed.

Analysts focused on how much of revenue is recurring platform revenue, what is delaying ReefIQ deals, and how the CAD 30 million credit facility will be used. Management said ReefIQ is newly launched and not yet broken out as recurring platform revenue, and that deal gating items include IT security/data governance, legal/procurement, and scoping of initial deployments. On the financing side, Scott said the facility cannot be used until the credit agreement is completed within 60 days and that draws will be made as needed, while Jennifer said it does not replace the ring-fenced Cayman-style financing structure, which remains in progress.